Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

Endocrine-Related Cancer

Volumn 13, Issue 2, 2006, Pages 541-558

  Capurso, G ^a,b   Lattimore, S ^b   Crnogorac Jurcevic, T ^b   Panzuto, F ^a   Milione, M ^a   Bhakta, V ^b   Campanini, N ^d   Swift, S M ^c   Bordi, C ^d   Delle Fave, G ^a   Lemoine, N R ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; FATTY ACID BINDING PROTEIN; PROTEIN BRIDGING INTEGRATOR 1; PROTEIN TYROSINE KINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; ENDOCRINE TUMOR; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENOME; HISTOPATHOLOGY; HUMAN; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS ISLET CELL; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ADULT; AGED; CLUSTER ANALYSIS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 33745092361     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01153     Document Type: Article

References (59)

1. lck in T cell signalling and thymocyte development. Advances in Immunology 56 151-178.
2. Ansell SM, Mahoney MR, Green EM & Rubin J 2004 Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity. American Journal of Clinical Oncology 27 232-235.
3. Baudin E, Bidart JM, Rougier P, Lazar V, Ruffle P, Ropers J, Ducreux M, Troalen F, Sabourin JC & Comoy E 1999 Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 84 69-75.
4. Benjamini Y & Hochberg Y 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57 289-300.
5. Bernacka K, Kuryliszyn-Moskal A & Sierakowski S 1998 The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis. Cancer 15 1188-1193.
6. Bernards R & Weinberg RA 2002 A progression puzzle. Nature 418 823.
7. lck travels to the plasma membrane via exocytic pathway. Journal of Cell Biology 145 457-468.
8. Bloomston M, Durkin A, Yang I, Rojiani M, Rosemurgy AS, Enkmann S, Yeatman TJ & Zervos EE 2004 Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies. Annals of Surgical Oncology 11 413-419.
9. Bolstad BM, Irizarry RA, Astrand M & Speed TP 2003 A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 185-193.
10. Capurso G, Crnogorac-Jurcevic T, Milione M, Panzuto F, Campanini N, Dowen SE, Di Florio A, Sette C, Bordi C, Lemoine NR et al. 2005 Peanut-like 1 (Septin 5) gene expression in normal and neoplastic human endocrine pancreas. Neuroendocrinology 81 311-321.
11. Corleto VD, Delle Fave G & Jensen RT 2002 Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances. Digestive and Liver Disease 34 668-680.
12. Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL & Gatter K 2005 Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. British Journal of Cancer 92 94-101.
13. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP & Lemoine NR 2003 Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. Journal of Pathology 201 63-74.
14. Dilley WG, Kalyanaraman S, Verma S, Cobb JP, Laramie JM & Lairmore TC 2005 Global gene expression in neuroendocrine tumors from patients with MEN-I syndrome. Molecular Cancer 4 9.
15. DuHadaway JB, Lynch FJ, Brisbay S, Bueso-Ramos C, Troncoso P, McDonnell T & Prendergast GC 2003 Immunohistochemical analysis of BIN1/amphiphysin II in human tissues: diverse sites of nuclear expression and losses in prostate cancer. Journal of Cellular Biochemistry 88 635-642.
16. Fidler IJ & Hart IR 1982 Biological diversity in metastatic neoplasms: origins and implications. Science 217 893-895.
17. Fjallskog ML, Lejonklou MH, Oberg KE, Eriksson BK & Janson ET 2003 Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clinical Cancer Research 9 1469-1473.
18. Ge K, Minhas F, Duhadaway J, Mao NC, Wilson D, Buccafusca R, Sakamuro D, Nelson P, Malkowicz SB & Tomaszewski J 2000 Loss of heterozygosity and tumor suppressor activity of BIN1 in prostate carcinoma. International Journal of Cancer 86 155-161.
19. Grutzmann R, Saeger HD, Luttges J, Schackert HK, Kalthoff H, Kloppel G & Pilarsky C 2004 Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives. International Journal of Colorectal Diseases 19401-413.
20. Grutzmann R, Boriss H, Ammerpohl O, Luttges J, Kalthoff H, Schackert HK, Kloppel G, Saeger HD & Pilarsky C 2005 Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 24 5079-5088.
21. Guo SS, Wu X, Shimoide AT, Wong J, Moatamed F & Sawicki MP 2003 Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours. Journal of Endocrinology 179 73-79.
22. Han X, Fiehler R & Broze GJ Jr 1998 Isolation of a protein Z-dependent plasma ptotease inhibitor. PNAS 95 9250-9255.
23. Hansel DE, Rahman A, House M, Ashfaq R, Berg K, Yeo CJ & Maitra A 2004 Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. Clinical Cancer Research 10 6152-6158.
24. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C & Wang H 2004 Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100 1110-1122.
25. Hess KR, Fuller GN, Rhee CH & Zhang W 2001 Statistical pattern analysis of gene expression profiles for glioblastoma tissues and cell lines. International Journal of Molecular Medicine 8 183-188.
26. Higashiyama M, Doi O, Kodama K, Yokouchi H & Tateishi R 1992 An evaluation of the prognostic significance of α-1-antitrypsin expression in adenocarcinoma of the lung: an immunohistochemical analysis. British Journal of Cancer 65 300-302.
27. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B & Speed TP 2003 Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Research 31 e15.
28. Ishikawa J, Kaisho T, Tomizawa H, Lee BO, Kobune Y, Inazawa J, Oritani K, Itoh M, Ochi T, Ishihara K et al. 1995 Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26 527-534.
29. Jin L, Wang H, Narita T, Kikuno R, Ohara O, Shihara N, Nishigori T, Horikawa Y & Takeda J 2003 Expression profile of mRNAs from human pancreatic islet tumors. Journal of Molecular Endocrinology 31 519-528.
30. Kaltsas GA, Besser GM & Grossman AG 2004 The diagnosis and management of advanced neuroendocrine tumors. Endocrine Reviews 25 458-511.
31. Karashima S, Kataoka H, Itoh H, Maruyama R & Koono M 1990 Prognostic significance of alfa-1-antitrypsin in early stage of colorectal carcinomas. International Journal of Cancer 45 244-250.
32. Kataoka H, Uchino H, Iwamura T, Seiki M, Nabeshima K & Koono M 1999 Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alfa1-proteinase inhibitor generated by matrix metalloproteinases. American Journal of Pathology 154 457-468.
33. Koehler A, Bataille F, Schmid C, Ruemmele P, Waldeck A, Blaszyk H, Hartmann A, Hofstaedter F & Dietmaier W 2004 Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. Journal of Pathology 204 65-74.
34. Krystal GW, DeBerry CS, Linnekin D & Litz J 1998 Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1. Cancer Research 58 4660-4666.
35. Lacroix M, Toillon RA & Leclercq G 2004 Stable portrait of breast tumors during progression: data from biology, pathology and genetics. Endocrine-Related Cancer 11 497-522.
36. Lahdesmaki H, Hao X, Sun B, Hu L, Yli-Harja O, Shmulevich I & Zhang W 2004 Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis. International Journal of Oncology 24 1589-1596.
37. Lam KY & Lo CY 1998 Role of p53 tumor suppressor gene in pancreatic endocrine tumors of Chinese patients. American Journal of Gastroenterology 93 1232-1235.
38. Maitra A, Hansel DE, Argani P, Ashfaq R, Rahman A, Naji A, Deng S, Geradts J, Hawthorne L & House MG 2003 Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clinical Cancer Research 95 988-995.
39. Nakamura K, Chijiiwa Y & Nawata H 1996 Augmented expression of LCK message directed from the downstream promoter in human colorectal cancer specimens. European Journal of Cancer 32 1401-1407.
40. Oberg K & Eriksson B 2005 Endocrine tumours of the pancreas. Best practice and research. Clinical Gastroenterology 19 753-781.
41. O'Toole D, Hentic O, Corcos O & Ruszniewski P 2004 Chemotherapy for gastro-enteropancreatic endocrine tumours. Neuroendocrinology 80 (Suppl 1) 79-84.
42. Ozaki S, Kosaka M, Wakahara Y, Ozaki Y, Tsuchiya M, Koishihara Y, Goto T & Matsumoto T 1999 Humanized anti-HM 1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells. Blood 93 3922-3930.
43. Panzuto F, Falconi M, Nasoni S, Angeletti S, Moretti A, Bezzi M, Gualdi G, Pollettini E, Sciuto R, Festa A et al. 2003 Staging of digestive endocrine tumours using helical computer tomography and somatostatin receptor scintigraphy. Annals of Oncology 14 586-591.
44. Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S et al. 2005 Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocrine-Related Cancer 12 1083-1092.
45. Plockinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Oberg K & Reubi JC 2004 Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 80 394-424.
46. Rew SB, Peggs K, Sanjuan I, Pizzey AR, Koishihara Y, Kawai S, Kosaka M, Ozaki S, Chain B & Yong KL 2005 Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24. Clinical Cancer Research 11 3377-3384.
47. Ricordi C, Lacy PE, Finke EH, Olack BJ & Scharp DW 1988 Automated method for isolation of human pancreatic islets. Diabetes 37 413-420.
48. Sarret P, Esdaile MJ, McPherson PS, Schonbrunn A, Kreienkamp HJ & Beaudet A 2004 Role of amphiphysin II in somatostatin receptor trafficking in neuroendocrine cells. Journal of Biological Chemistry 279 8029-8037.
49. Solcia E, Klöppel G & Sobin LH in collaboration with 9 pathologists from 4 countries 2000 Histological Typing of Endocrine Tumors, edn 2, pp 1-5. World Health Organization. Berlin, Heidelberg, New York: Springer Verlag.
50. Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzilli R & Corinaldesi R 2005 Endocrine pancreatic tumors: factors correlated with survival. Annals of Oncology 16 1806-1810.
51. Van Gent D, Sharp P, Morgan K & Kalsheka N 2003 Serpins: structure, function and molecular evolution. International Journal of Biochemistry and Cell Biology 35 1536-1547.
52. Veillette A, Foss FM, Sausville EA, Bolen JB & Rosen N 1987 Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. Oncogene Research 1 357-374.
53. Walter-Yohrling J, Cao X, Callahan M, Weber W, Morgenbesser S, Madden SL, Wang C & Teicher BA 2003 Identification of genes expressed in malignant cells that promote invasion. Cancer Research 63 8939-8947.
54. Wang XC, Hu RM, Xu SY, Song HD, Mao YF, Fan HY, Yu F, Mou B, Gu YY, Xu LQ et al. 2004 Gene expression profiling in human insulinoma tissue: genes involved in insulin secretion pathway and cloning of novel full-length cDNAs. Endocrine-Related Cancer 11 295-303.
55. Wechsler-Reya R, Sakamuro D, Zhang J, Duhadaway J & Prendergast GC 1997 Structural analysis of the human BIN1 gene. Journal of Biological Chemistry 50 31453-31458.
56. White SA, Davies JE, Pollard C, Swift SM, Clayton HA, Sutton CD, Weymss-Holden S, Musto PP, Berry DP & Dennison AR 2001 Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Annals of Surgery 233 423-431.
57. Wojtukiewicz MZ, Rucinska M, Kloczko J, Dib A & Galar M 1998 Profiles of plasma serpins in patients with advanced malignant melanoma, gastric cancer and breast cancer. Haemostasis 28 7-13.
58. Yezhelyev MV, Koehl G, Guba M, Brabletz T, Jauch KW, Ryan A, Barge A, Green T, Fennell M & Bruns CJ 2004 Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clinical Cancer Research 10 8028-8036.
59. Zanner R, Gratzl M & Prinz C 2004 Expression of the endocytic proteins dynamin and amphiphysin in rat gastric enterochromaffin-like cells. Journal of Cell Science 117 2369-2376.